| STEC-HUS, atypical HUS and TTP are all diseases of complement activation M Noris, F Mescia, G Remuzzi Nature Reviews Nephrology 8 (11), 622-633, 2012 | 481 | 2012 |
| Analysis of the B cell receptor repertoire in six immune-mediated diseases RJM Bashford-Rogers, L Bergamaschi, EF McKinney, DC Pombal, ... Nature 574 (7776), 122-126, 2019 | 202 | 2019 |
| Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, ... Nature communications 11 (1), 6385, 2020 | 109 | 2020 |
| Combined point-of-care nucleic acid and antibody testing for SARS-CoV-2 following emergence of D614G spike variant P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... Cell Reports Medicine 1 (6), 2020 | 82 | 2020 |
| Impact of acute kidney injury and CKD on adverse outcomes in critically ill septic patients JA Neyra, F Mescia, X Li, B Adams-Huet, L Yessayan, J Yee, RD Toto, ... Kidney International Reports 3 (6), 1344-1353, 2018 | 28 | 2018 |
| Urine klotho is lower in critically ill patients with versus without acute kidney injury and associates with major adverse kidney events JA Neyra, X Li, F Mescia, V Ortiz-Soriano, B Adams-Huet, J Pastor, MC Hu, ... Critical care explorations 1 (6), e0016, 2019 | 22 | 2019 |
| Treatment of COVID-19 with remdesivir in the absence of humoral immunity: a case report. Nat Commun 11: 6385 MS Buckland, JB Galloway, CN Fhogartaigh, L Meredith, NM Provine, ... | 9 | 2020 |
| Combined point of care SARS-CoV-2 nucleic acid and antibody testing in suspected moderate to severe COVID-19 disease P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... | 3 | 2020 |
| Combined point of care nucleic acid and antibody testing for SARS-CoV-2: a prospective cohort study in suspected moderate to severe COVID-19 disease P Mlcochova, D Collier, A Ritchie, SM Assennato, M Hosmillo, N Goel, ... medRxiv, 2020.06. 16.20133157, 2020 | 1 | 2020 |
| 042. PROFILING THE AUTOANTIBODY REPERTOIRE IN VASCULITIS E Pin, D Just, F Mescia, P Heeringa, Y van Sleen, A Rutgers, E Brouwer, ... Rheumatology 58 (Supplement_2), kez057. 041, 2019 | 1 | 2019 |
| Kidney transplantation from a donor with acute kidney injury: an unexpected outcome F Mescia, R Piras, M Noris, G Marchetti, G Rossini, G Remuzzi, ... American Journal of Transplantation 14 (4), 977-978, 2014 | 1 | 2014 |
| Successful treatment of COVID-19 with remdesivir in the absence of humoral immunity MS Buckland, J Galloway, CN Fhogartaig, L Meredith, NM Provine, ... | | 2020 |
| Successful treatment of COVID-19 with remdesivir in the absence of humoral immunity (preprint) MS Buckland, J Galloway, CN Fhogartaig, L Meredith, NM Provine, ... | | 2020 |
| 185. GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE L Wong, F Mescia, F Alberici, MJ Ball, B Baslund, P Brenchley, ... Rheumatology 58 (Supplement_2), kez060. 012, 2019 | | 2019 |
| GENETIC EVIDENCE OF EOSINOPHIL NUMBER UNDERPINNING PR3-AAV AND PLAUSIBLE HOST GENETIC PREDISPOSITION TO MICROBIAL DRIVERS OF DISEASE L Wong, F Mescia, F Alberici, MJ Ball, B Baslund, P Brenchley, ... RHEUMATOLOGY 58, 80-81, 2019 | | 2019 |
| Prevention and Therapeutic Management of Bleeding in Dialysis Patients F Mescia, P Boccardo, M Galbusera, G Remuzzi Handbook of Dialysis Therapy: Fifth Edition, 334-345, 2017 | | 2017 |
| Nuovo Approccio nel Trattamento Dell'ipertensione Arteriosa Resistente Mediante Anastomosi Artero-venosa F Pieruzzi, F Mescia Giornale di Tecniche Nefrologiche e Dialitiche 27 (2), 67-69, 2015 | | 2015 |
| Role of Immunosuppressive Therapy on Humoral Autoimmune Response after Islet Allotransplantation: A Long Term Survey P Maffi, L Piemonti, F Mescia, M Scavini, R Melzi, R Nano, P Magistretti, ... AMERICAN JOURNAL OF TRANSPLANTATION 11, 248-248, 2011 | | 2011 |
